|
|
IRZSMU >
Кафедри >
Кафедра клінічної фармакології, фармації, фармакотерапії і косметології >
Наукові праці. (Клінічна фармакологія) >
Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс:
http://dspace.zsmu.edu.ua/handle/123456789/24904
|
| Название: | The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients |
| Авторы: | Berezin, A. E. Kremzer, O. O. Martovitskaya, Yu. V. Samura, T. A. Berezina, T. A. Березін, О. Є. Кремзер, Олександр Олександрович Самура, Тетяна Олександрівна |
| Ключевые слова: | Chronic Heart Failure Microparticles Thyroid Dysfunction |
| Дата публикации: | 2015 |
| Библиографическое описание: | The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients / A. E. Berezin, O. O. Kremzer, Yu. V. Martovitskaya,T. A. Samura,T. A. Berezina // Reviews in Cardiovascular Medicine. - 2015. - Vol. 4, N 4. - P. e29094. - https://doi.org/10.5812/cardiovascmed.29094. |
| Аннотация: | Background: Subclinical hypothyroidism (SH) is diagnosed biochemically by the presence of normal serum free thyroxine concentration, in conjunction with an elevated serum thyroid-stimulating hormone level. Recent studies have demonstrated the frequent association between SH and cardiovascular diseases and risk factors.
Objectives: To evaluate the impact of SH on patterns of circulating endothelial-derived microparticles, (EMPs) among chronic heart failure (CHF) patients
Patients and Methods: This is a retrospective study involving a cohort of 388 patients with CHF. Fifty-three CHF subjects had SH and 335 patients were free from thyroid dysfunction. Circulating levels of N-terminal-pro brain natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein (hs-CRP), thyroid-stimulating hormone (TSH), total and free thyroxine (T4), and triiodothyronine (T3), and endothelial apoptotic microparticles (EMPs), were measured at baseline. SH was defined, according to contemporary clinical guidelines, as a biochemical state associated with an elevated serum TSH level of greater 10 μU/L and normal basal free T3 and T4 concentrations.
Results: Circulating CD31+/annexin V+ EMPs were higher in patients with SH compared to those without SH. In contrast, activated CD62E+ EMP numbers were not significantly different between both patient cohorts. Using uni (bi) variate and multivariate age- and gender-adjusted regression analysis, we found several predictors that affected the increase of the CD31+/annexin V+ to CD62E+ ratio in the patient study population. The independent impact of TSH per 6.5 μU/L (odds ratio [OR] = 1.23, P = 0.001), SH (OR = 1.22, P = 0.001), NT-proBNP (OR = 1.19, P = 0.001), NYHA class (OR = 1.09, P = 0.001), hs-CRP per 4.50 mg/L (OR = 1.05, P = 0.001), dyslipidemia (OR = 1.06, P = 0.001), serum uric acid per 9.5 mmol/L (OR = 1.04, P = 0.022) on the increase in the CD31+/annexin V+ to CD62E+ ratio, was determined.
Conclusions: We believe that the SH state in CHF patients may be associated with the impaired pattern of circulating EMPs, with the predominantly increased number of apoptotic-derived microparticles. |
| URI: | http://dspace.zsmu.edu.ua/handle/123456789/24904 |
| Располагается в коллекциях: | Наукові праці. (Клінічна фармакологія)
|
Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.
|